Welcome to LookChem.com Sign In|Join Free

CAS

  • or

130178-43-7

Post Buying Request

130178-43-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • Morphinan-3-ol,4,5-epoxy-17-methyl-6-[(5-nitro-2-pyridinyl)dithio]-, (5a,6b)- (9CI)

    Cas No: 130178-43-7

  • No Data

  • No Data

  • No Data

  • Chemical Co.Ltd
  • Contact Supplier

130178-43-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 130178-43-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,0,1,7 and 8 respectively; the second part has 2 digits, 4 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 130178-43:
(8*1)+(7*3)+(6*0)+(5*1)+(4*7)+(3*8)+(2*4)+(1*3)=97
97 % 10 = 7
So 130178-43-7 is a valid CAS Registry Number.

130178-43-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name (4R,4aR,7R,7aS)-3-methyl-7-[(5-nitropyridin-2-yl)disulfanyl]-2,4,4a,5,6,7,7a,13-octahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-9-ol

1.2 Other means of identification

Product number -
Other names NPDM

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:130178-43-7 SDS

130178-43-7Downstream Products

130178-43-7Relevant articles and documents

Ligand recognition in μ opioid receptor: Experimentally based modeling of μ opioid receptor binding sites and their testing by ligand docking

Sagara, Takeshi,Egashira, Hiromu,Okamura, Mikako,Fujii, Ikuo,Shimohigashi, Yasuyuki,Kanematsu, Ken

, p. 2151 - 2166 (1996)

For three-dimensional understanding of the mechanisms that control potency and selectivity of the ligand binding at the atomic level, we have analysed opioid receptor-ligand interaction based on the receptor's 3D mode. As a first step, we have constructed molecular models for the multiple opioid receptor subtypes using bacteriorhodopsin as a template. The S-activated dihydromorphine derivatives should serve as powerful tools in mapping the three-dimensional structure of the μ opioid receptor, including the nature of the agonist-mediated conformational change that permits G protein-coupling to 'second messenger' effector molecules, and in identifying specific ligand-binding contacts with the μ opioid receptor. The analyses of the interactions of some opioid ligands with the predicted ligand binding sites are consistent with the results of the affinity labeling experiments.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 130178-43-7